CYP2E1 and metabolic dysfunction-associated steatotic liver disease: The expression of CYP2C (Fisher et al., 2009), CYP2E1 (Bell et al., 2011) and CYP3A4 (Fisher et al., 2009) was upregulated in the liver of the NAFLD model.